Νατσαρίδης, Ε., & Natsaridis, E. (2022). Development of liposomal formulations of Moxifloxacin for intraocular administration for the therapy/prevention of post-operative endopthalmitis.
Chicago Style (17th ed.) CitationΝατσαρίδης, Ευάγγελος, and Evangelos Natsaridis. Development of Liposomal Formulations of Moxifloxacin for Intraocular Administration for the Therapy/prevention of Post-operative Endopthalmitis. 2022.
MLA (8th ed.) CitationΝατσαρίδης, Ευάγγελος, and Evangelos Natsaridis. Development of Liposomal Formulations of Moxifloxacin for Intraocular Administration for the Therapy/prevention of Post-operative Endopthalmitis. 2022.
Warning: These citations may not always be 100% accurate.
